Immunophenotype of Measurable Residual Blast Cells as an Additional Prognostic Factor in Adults with B-Cell Acute Lymphoblastic Leukemia

Measurable residual disease (MRD) is a well-known independent prognostic factor in acute leukemias, and multicolor flow cytometry (MFC) is widely used to detect MRD. MFC is able not only to enumerate MRD accurately but also to describe an antigen expression profile of residual blast cells. However,...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yulia Davydova, Irina Galtseva, Nikolay Kapranov, Ksenia Nikiforova, Olga Aleshina, Yulia Chabaeva, Galina Isinova, Ekaterina Kotova, Andrey Sokolov, Vera Troitskaya, Sergey Kulikov, Elena Parovichnikova
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-12-01
Col·lecció:	Diagnostics
Matèries:	flow cytometry immunophenotype measurable residual disease acute lymphoblastic leukemia
Accés en línia:	https://www.mdpi.com/2075-4418/13/1/21
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!